Novartis AG (NVS)
97.51
+0.23
(+0.24%)
USD |
NYSE |
Apr 24, 11:15
Novartis Shares Outstanding: 2.044B for Dec. 31, 2023
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
December 31, 2023 | 2.044B |
September 30, 2023 | 2.055B |
June 30, 2023 | 2.068B |
March 31, 2023 | 2.097B |
December 31, 2022 | 2.120B |
September 30, 2022 | 2.151B |
June 30, 2022 | 2.183B |
March 31, 2022 | 2.213B |
December 31, 2021 | 2.235B |
September 30, 2021 | 2.237B |
June 30, 2021 | 2.237B |
March 31, 2021 | 2.245B |
December 31, 2020 | 2.257B |
September 30, 2020 | 2.274B |
June 30, 2020 | 2.289B |
March 31, 2020 | 2.289B |
December 31, 2019 | 2.265B |
September 30, 2019 | 2.265B |
June 30, 2019 | 2.292B |
May 14, 2019 | 2.294B |
March 31, 2019 | 2.323B |
December 31, 2018 | 2.311B |
September 30, 2018 | 2.31B |
June 30, 2018 | 2.322B |
May 16, 2018 | 2.318B |
Date | Value |
---|---|
March 31, 2018 | 2.331B |
December 31, 2017 | 2.317B |
June 30, 2017 | 2.343B |
March 31, 2017 | 2.366B |
December 31, 2016 | 2.374B |
September 30, 2016 | 2.376B |
June 30, 2016 | 2.381B |
March 31, 2016 | 2.381B |
December 31, 2015 | 2.374B |
September 30, 2015 | 2.396B |
June 30, 2015 | 2.415B |
March 31, 2015 | 2.420B |
December 31, 2014 | 2.399B |
September 30, 2014 | 2.419B |
June 30, 2014 | 2.426B |
March 31, 2014 | 2.447B |
December 31, 2013 | 2.426B |
September 30, 2013 | 2.435B |
June 30, 2013 | 2.447B |
March 31, 2013 | 2.457B |
December 31, 2012 | 2.421B |
September 30, 2012 | 2.419B |
June 30, 2012 | 2.418B |
March 31, 2012 | 2.422B |
January 19, 2012 | 2.407B |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
2.044B
Minimum
Dec 31 2023
2.294B
Maximum
May 14 2019
2.205B
Average
2.237B
Median
Shares Outstanding Benchmarks
Sandoz Group AG | 431.00M |
Roche Holding AG | 6.378B |
Amgen Inc | 535.92M |
Incyte Corp | 224.53M |
MorphoSys AG | 150.41M |